LEGN - Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Socie
LEGN - Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.